LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | OSI-027 | 1.11 | uM | LJP6 | 3 | E09 | 72 | hr | 1476 | 1951 | 3694 | 0.5282 | 0.2139 |
| SK-BR-3 | XMD11-85h | 1.11 | uM | LJP6 | 1 | P21 | 72 | hr | 1476 | 3160 | 3694 | 0.8554 | 0.7592 |
| SK-BR-3 | XMD11-85h | 1.11 | uM | LJP6 | 2 | P21 | 72 | hr | 1476 | 3150 | 3694 | 0.8527 | 0.7546 |
| SK-BR-3 | XMD11-85h | 1.11 | uM | LJP6 | 3 | P21 | 72 | hr | 1476 | 2723 | 3694 | 0.7371 | 0.5621 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 1 | M03 | 72 | hr | 1476 | 2780 | 3694 | 0.7526 | 0.5878 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 2 | M03 | 72 | hr | 1476 | 2768 | 3694 | 0.7493 | 0.5824 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 3 | M03 | 72 | hr | 1476 | 2843 | 3694 | 0.7696 | 0.6162 |
| SK-BR-3 | WH-4-025 | 1.11 | uM | LJP5 | 1 | O09 | 72 | hr | 1476 | 3310 | 3694 | 0.8960 | 0.8268 |
| SK-BR-3 | WH-4-025 | 1.11 | uM | LJP5 | 2 | O09 | 72 | hr | 1476 | 3029 | 3694 | 0.8200 | 0.7001 |
| SK-BR-3 | WH-4-025 | 1.11 | uM | LJP5 | 3 | O09 | 72 | hr | 1476 | 2951 | 3694 | 0.7989 | 0.6649 |
| SK-BR-3 | WZ-4-145 | 1.11 | uM | LJP6 | 1 | J21 | 72 | hr | 1476 | 1730 | 3694 | 0.4683 | 0.1142 |
| SK-BR-3 | WZ-4-145 | 1.11 | uM | LJP6 | 2 | J21 | 72 | hr | 1476 | 1963 | 3694 | 0.5314 | 0.2193 |
| SK-BR-3 | WZ-4-145 | 1.11 | uM | LJP6 | 3 | J21 | 72 | hr | 1476 | 2042 | 3694 | 0.5528 | 0.2549 |
| SK-BR-3 | XMD16-144 | 1.11 | uM | LJP5 | 1 | M09 | 72 | hr | 1476 | 1500 | 3694 | 0.4061 | 0.0105 |
| SK-BR-3 | XMD16-144 | 1.11 | uM | LJP5 | 2 | M09 | 72 | hr | 1476 | 1441 | 3694 | 0.3901 | -0.0161 |
| SK-BR-3 | XMD16-144 | 1.11 | uM | LJP5 | 3 | M09 | 72 | hr | 1476 | 1391 | 3694 | 0.3766 | -0.0387 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 1 | P15 | 72 | hr | 1476 | 3253 | 3694 | 0.8806 | 0.8011 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 2 | P15 | 72 | hr | 1476 | 3231 | 3694 | 0.8747 | 0.7912 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 3 | P15 | 72 | hr | 1476 | 3025 | 3694 | 0.8189 | 0.6983 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 1 | H03 | 72 | hr | 1476 | 1097 | 3694 | 0.2970 | -0.1713 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 2 | H03 | 72 | hr | 1476 | 1158 | 3694 | 0.3135 | -0.1437 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 3 | H03 | 72 | hr | 1476 | 1168 | 3694 | 0.3162 | -0.1392 |
| SK-BR-3 | BX-912 | 1.11 | uM | LJP5 | 1 | L21 | 72 | hr | 1476 | 1369 | 3694 | 0.3706 | -0.0486 |
| SK-BR-3 | BX-912 | 1.11 | uM | LJP5 | 2 | L21 | 72 | hr | 1476 | 1228 | 3694 | 0.3324 | -0.1122 |
| SK-BR-3 | BX-912 | 1.11 | uM | LJP5 | 3 | L21 | 72 | hr | 1476 | 1338 | 3694 | 0.3622 | -0.0626 |